Trenzyme GmbH licenses SEFEX cell line technology from Celonic AG

Trenzyme GmbH licenses SEFEX cell line technology from Celonic AG

Konstanz/Germany based contract research organization Trenzyme GmbH and Basel/Switzerland based Celonic AG today announced the closure of a licence agreement on Celonics CHO-K1 based cell line expression platform SEFEX. Under the terms of the deal, Trenzyme acquires the non-exclusive rights and know-how on this technology to establish high performance cell lines for R&D and GMP production purposes for its clients.
The SErum Free EXpression technology,SEFEX, is a royalty-free cell li

Allocadia–s Twin Co-Founders Named to Forty Under 40 List by BIV

Allocadia–s Twin Co-Founders Named to Forty Under 40 List by BIV

VANCOUVER, BRITISH COLUMBIA — (Marketwired) — 10/05/15 — Editors Note: There is a photo associated with this press release.Allocadia founders Kristine Steuart and Katherine Berry have been named among BC–s top entrepreneurs, executives and professionals in this year–s Business in Vancouver (BIV) Forty Under 40 awards.The BIV Forty Under 40 each year highlights the forty most outstanding people in business under the age of 40 throughout the province."I speak for the entire team at Allo